¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Syndrome, giant platelet"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Taussig-Bing syndrome
    Ÿ¿ì½Ã±×-ºùÁõÈıº
  • tarsal tunnel syndrome
    ¹ß¸ñ±¼ÁõÈıº, Á·±Ù°üÁõÈıº
  • ulnar tunnel syndrome
    ÀÚ±¼ÁõÈıº, ô°ñ°üÁõÈıº
  • uncombable hair syndrome
    ¾ûÅ´ÅÐÁõÈıº
  • velocardiofacial syndrome
    ÀÔõÀå½ÉÀå¾ó±¼ÁõÈıº, ±¸°³½ÉÀå¾È¸éÁõÈıº
  • vanishing lung syndrome
    ¼Ò¸êÆóÁõÈıº, »ç¶óÁö´ÂÇãÆÄÁõÈıº
  • vanishing testes syndrome
    ¼Ò¸ê°íȯÁõÈıº
  • Wiskott-Aldrich syndrome
    ºñ½ºÄÚÆ®-¿Ãµå¸®Ä¡ÁõÈıº
  • withdrawal syndrome
    ±Ý´ÜÁõÈıº
  • Wolff-Parkinson-White syndrome
    ¿ùÇÁ-ÆÄŲ½¼-È­ÀÌÆ®ÁõÈıº
  • wasting syndrome
    ¼Ò¸ðÁõÈıº
  • Waterhouse-Friderichsen syndrome
    ¿öÅÍÇϿ콺-ÇÁ¸®µ¥¸¯¼¾ÁõÈıº
  • Werner¡¯s syndrome
    º£¸£³ÊÁõÈıº
  • Wernicke¡¯s syndrome
    º£¸£´ÏÄÉÁõÈıº
  • X-linked lymphoproliferative syndrome
    X¿¬°ü¸²ÇÁ±¸Áõ½ÄÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Raynaud s syndrome
    ·¹À̳ëÁõÈıº.
  • Refsums syndrome
    ·¾¼ûÁõÈıº
  • Reiter s syndrome
    ¶óÀÌÅÍÁõÈıº.
  • Reiter syndrome
    ¶óÀÌÅÍÁõÈıº
  • Reiters syndrome
    ¶óÀÌÅÍ ÁõÈıº
  • Reye s syndrome
    ¶óÀÌÁõÈıº.
  • Rh deficiency syndrome
    Rh °áÇÌÁõÈıº
  • Rh null syndrome
    Rh ¿µ<Á¦·Î>ÁõÈıº
  • Riley Day syndrome
    ¸±¸®-µ¥ÀÌÁõÈıº.
  • Riley-Smith syndrome
    ¸±¸® ½º¹Ì½º ÁõÈıº
  • Robinsons syndrome
    ·Îºó½¼ ÁõÈıº
  • Rombergs disease = Romberg syndrome
    ·Òº£¸£Å©º´
  • Rosenthal-Kloepfer syndrome
    ·ÎÁ¨Å» Ŭ·Î¿¡ÆÛ ÁõÈıº
  • Roth-Bielschowsky syndrome
    ·ÎÆ®-ºô¼î½ºÅ°ÁõÈıº
  • Rubinstein-Taybi syndrome
    ·çºó½ºÅ¸ÀÎ Å×À̺ñ ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • cholecysto-hepatic flexure adhesion syndrome
    ´ã³¶°áÀå°£°îºÎ À¯ÂøÁõÈıº(´ã³¶°áÀå°£°îºÎÀ¯ÂøÁõÈıº).
  • chromaosomal breakage syndrome
  • chromosome longarm deletion syndrome
    ¿°»öüÀåÁö°á¼ÕÁõÈıº(¡­íþò¦ÌÀáßñøý¦ÏØ).
  • chromosome-breakage syndrome
    ¿°»öü-ºÐÇØ ÁõÈıº(æøßäô÷ÝÂú°ñøý¦ÏØ)
  • chronic fatigue syndrome
    ¸¸¼º ÇÇ·ÎÁõÈıº
  • chronic infantile neurological cutaneous articular syndrome
    ¸¸¼º À¯¾Æ ½Å°æ ÇǺΰüÀý ÁõÈıº
  • chronic organic brain syndrome
    ¸¸¼º ±âÁú¼º ³úÁõÈıº
  • chronic social breakdown syndrome
    ¸¸¼º »çȸ¼º ºØ±«ÁõÈıº
  • churg-strauss syndrome
    ó¸£±× ½ºÆ®¶ó¿ì½º ÁõÈıº(¡­ñøý¦ÏØ)
  • cleft palate lateral synechia syndrome
    ±¸°³¿­ ÃøÀ¯Âø ÁõÈıº
  • cleft palate syndrome
    ÀÔõÀå°¥¸²ÁõÈıº
  • clinical syndrome
    ÀÓ»ó(Àû) ÁõÈıº
  • clumsy child syndrome
    µÐÇÑ ¾Æµ¿ÁõÈıº(ä®ÔÛñøý¦ÏØ)
  • clumsy hand syndrome
    ¼­Å÷¼Õ ÁõÈıº(¡­ñøý¦ÏØ).
  • clumsy-hand-dysarthric syndrome
    µÐ¼ö±¸À½Àå¾Ö ÁõÈıº
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
PCFT platelet complement fixation test
PD-ECGF platelet-derived endothelial cell growth factor
PDGF platelet-derived growth factor
PDGFA platelet-derived growth factor, A chain
PDGFR platelet-derived growth factor receptor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
MDS 7--myelodysplastic syndrome
ACS Abdominal compartment syndrome
AIDS Acquire Immune Deficiency Syndrome
AIDS Acquired Immune Deficiency Disease Syndrome
AVWS Acquired von Willebrand syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • monofixation syndrome
    ´Ü¾È Áֽà ÁõÈıº
  • motor syndrome
    ¿îµ¿ ÁßÃß ÁõÈıº
  • mucocutaneous ocular syndrome
    ÇǺΠÁ¡¸· ¾È ÁõÈıº
  • Muenchausen's syndrome
    ¹Â¿£ÇÏ¿ìÁ¨ ÁõÈıº
    ±Ø´ÜÀûÀÎ ÇãÀ§ÀÇ º´·ÂÀ» ¸»Çϸç, ¶§·Î´Â ±Þ¼º º¹ºÎ Áõ»ó, ƯÈ÷ ÃâÇ÷, ¿Ü»ó µîÀ» °¡ÀåÇϸ鼭 ÀÔ¿øÀ» ÇÏ´Ù°¡ ÀÚ¹ßÀûÀ¸·Î Åð¿øµµ ÇÏ´Â ±â±«ÇÑ »óÅ·Π´ë°³ È÷½ºÅ׸®, ºÐ¿­Áõ ¶Ç´Â ÇÇÇã¾Ö ȯÀÚ.
  • multiple hamartoma syndrome
    ´Ù¹ß¼º °ú¿ÀÁ¾ ÁõÈıº
    ´Ù¹ß¼ºÀÌ¸ç ¸ð¹Ý ¸ð¾çÀÎ ¿Ü¹è¿±¼º, Á߹迱¼º ¹× ³»¹è¿±¼ºÀÇ ½Å»ý¹°¼º ±âÇüÀ» Ư¡À¸·Î ÇÏ´Â À¯Àüº´. ¾ó±¼ ¹× ±¸°­ Á¡¸·ÀÇ ±¸ÁøÀÌ °¡Àå Æ¯Â¡ÀûÀÎ º´º¯ÀÌ´Ù. ±× ¿ÜÀÇ º´º¯Àº ÇǺÎ, °©»ó¼±
  • multiple lentigines syndrome
    ´Ù¹ß¼º ÈæÀÚ ÁõÈıº
    »ó¿°»öü¼º ¿ì¼ºÀÇ À¯Àü¼º ÁõÈıºÀ¸·Î¼­ ´Ù¹ß¼º °ËÀº »ç¸¶±Í, ¹«ÁõÈıº¼º ½ÉÀå °áÇÔ. ƯÀÌÇÑ ¾ó±¼ ¸ð¾ç, Æóµ¿¸Æ ÇùÂø, Áö°¢ ½Å°æ¼º ³­Ã», °ñ°Ý ÀÌ»ó, ¾ç¾È °Ý¸®, ¼º±â ±âÇü µîÀ» ³ªÅ¸³½´Ù.
  • multiple neuroma syndrome
    ´Ù¹ß¼º ½Å°æÁ¾ ÁõÈıº
  • Munchausen's syndrome
    ½Åü Áõ»óÀ» ¼ö¹ÝÇÑ °¡À强 Áúȯ
    ÀüºÎ °ÅÁþ¸»ÀÎ ±×·²µíÇÑ º´·ÂÀ» À̾߱âÇϸ鼭 ½À°üÀûÀ¸·Î ÀÔ¿ø Ä¡·á¸¦ ¹Þ´Â »óÅÂ.
  • muscle compartment syndrome
    ±Ù ±¸¿ª ÁõÈıº
    ±Ù ±¸¿ª ³»ÀÇ »ê¼Ò ºÎÁ·À¸·Î ÀÎÇÏ¿© ±ÙÀ°¿¡ ÅëÁõÀ̳ª »»»»ÇÔÀÌ ¹ß»ýÇÑ °Í.
  • myasthenia gravis syndrome
    ÁßÁõ ±Ù¹«·Â ÁõÈıº
  • myeloblastic syndrome
    °ñ¼ö¾Æ±¸ ÁõÈıº
  • myelodysplastic syndrome
    °ñ¼ö ÀÌÇü¼º ÁõÈıº
  • myeloproliferative syndrome
    °ñ¼ö Áõ½Ä¼º ÁõÈıº
    Á¶Á÷ Çü¼º»ó ¿¬°üÀÌ ÀÖ´Â Áúȯ ±ºÀ» ÃÑĪÇÏ´Â °ÍÀ¸·Î, ´Ù¾çÇÑ ½Ã±â¿Í ´Ù¾çÇÑ Á¤µµ·Î °ñ¼ö ±¸¼º ¼¼Æ÷ÀÇ Çϳª ȤÀº ±× ÀÌ»óÀÇ ¼¼Æ÷°è»ç °ñ¼ö³» ¹× °ñ¼ö¿Ü·Î Áõ½ÄÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ±× ±¸¼º ¼¼Æ÷¿¡´Â °ñ¼ö±¸Çü, Àû¾Æ±¸Çü, °ÅÇÙ ¼¼Æ÷ÇüÀÇ ¼¼Æ÷ ¿Ü¿¡ ¼¼¸Á°ú °£¿±°è À¯·¡ÀÇ ¼¼Æ÷µµ Æ÷ÇԵȴÙ. À̵éÀÇ Áõ½Ä¼º Áúȯ¿¡´Â ±Þ¼º ¹× ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, Áø¼º ´ÙÇ÷Áõ, °ñ¼ö ÀÌÇü¼º, °ñ¼ö ¼¶À¯Á¾, º»Å¼º ÃâÇ÷¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ, ÀûÇ÷±¸ Áõ°¡¼º °ñ¼öÁõ µîÀÌ ÀÖ´Ù.
  • myofascial pain dysfunction syndrome
    ±Ù¸· µ¿Åë ±â´É Àå¾Ö ÁõÈıº, ±Ù¸· ÅëÁõ ±â´ÉÀå¾Ö ÁõÈıº
    µ¿ÀǾî=myofascial
  • myofascial pain syndrome
    ±Ù¸· µ¿Åë ÁõÈıº
    Fricton¿¡ ÀÇÇÏ¸é °¡Àå ÀϹÝÀûÀÎ ¸¸¼º ±ÙÀ° Àå¾Ö·Î¼­ À̰ÍÀº º¹ÇÕÀûÀÎ Àå¾Ö·Î ¾ÆÁ÷µµ ³í¶õÀÇ ´ë»óÀÌ µÇ°í ÀÖ´Â ¿ë¾îÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
gastrojejunal loop obstruction syndrome <syndrome> A complication of gastrojejunostomy, caused by acute or chronic obstruction of the afferent loop due to hernia, intussusception, kinking, volvulus, etc. It is characterised by pain and vomiting of bile-stained fluid and includes acute afferent loop obstruction and bilious vomiting.
(12 Dec 1998)
mallory-weiss syndrome <syndrome> Mucosal gastric tear, only 10% are purely oesophageal: most are at GE junction or proximal stomach, M greater than F, associated with retching, EtOH, massive haematemesis, abdominal pain, Diagnosis: endoscopy, Treatment: IA vasopressin see: oesophageal trauma
(12 Dec 1998)
velo-cardio-facial syndrome <syndrome> Also known as shprintzen syndrome, this more than is a congenital malformation (birth defect) syndrome with cleft palate, heart defect, abnormal face, and learning problems. The condition is therefore called the velo-cardio-facial (vcf) syndrome. (the velum is the soft palate). Other less frequent features include short stature, small-than-normal head (microcephaly), mental retardation, minor ear anomalies, slender hands and digits, and inguinal hernia. The cause is usually a microdeletion in chromosome band 22q11.2, just as in digeorge syndrome. Vcf and digeorge syndromes are different clinical expressions of essentially the same chromosome defect. Of essentially the same chromosome defect.
(12 Dec 1998)
papillary muscle syndrome Impaired function of a papillary muscle, usually due to ischemia or infarction, with resulting incompetence of the mitral valve.
Synonym: papillary muscle syndrome.
(05 Mar 2000)
gay bowel syndrome <syndrome> Gastrointestinal discomfort experienced by homosexual males; includes abdominal pain, cramps, bloating, flatulence, nausea, vomiting, or diarrhoea caused by enteric bacteria, viruses, fungi, zooparasites, or trauma.
(05 Mar 2000)
Papillon-Leage and Psaume syndrome <syndrome> An inherited syndrome, lethal in males, with varying combinations of defects of the oral cavity, face, and hands, including lobulated or bifid tongue, cleft or pseudocleft palate, tongue tumours, missing or malpositioned teeth, hypoplastic nasal alar cartilage, depressed nasal bridge, brachydactyly, clinodactyly, incomplete syndactyly, and, frequently, mental retardation.
There are two subtypes recognised. Type I (papillon-leage and psaume syndrome, gorlin-psaume syndrome) is inherited as an x-linked dominant trait and is found only in females and XXY males. Type II (mohr syndrome) is inherited as an autosomal recessive trait.
Inheritance: autosomal recessive and X-linked.
Synonym: OFD syndrome, orofaciodigital syndrome, Papillon-Leage and Psaume syndrome.
(05 Mar 2000)
Papillon-Lefevre syndrome <syndrome> A rare congenital hyperkeratosis of the palms and soles (palmoplantar keratoderma), with progessive destruction of the alveolar bone of both the deciduous and permanent teeth.
It occurs between the first and fifth years of life and has autosomal recessive inheritance.
Inheritance: autosomal recessive.
(05 Mar 2000)
Gelineau's syndrome <neurology> A disorder of sleep associated with excessive daytime sleepiness, involuntary daytime sleep episodes, disturbed nocturnal sleep and cataplexy.
Narcolepsy affects over 100,000 people in the United States and appears to have a genetic basis.
Symptoms usually begin in the patients twenties. Treatment often includes the use of amphetamines and-or tricyclic antidepressants.
(27 Sep 1997)
mandibulofacial dysotosis syndrome A hereditary disorder occurring in two forms: the complete form (franceschetti's syndrome) is characterised by antimongoloid slant of the palpebral fissures, coloboma of the lower lid, micrognathia and hypoplasia of the zygomatic arches, and microtia. It is transmitted as an autosomal trait. The incomplete form (treacher collins syndrome) is characterised by the same anomalies in less pronounced degree. It occurs sporadically, but an autosomal dominant mode of transmission is suspected.
(12 Dec 1998)
mandibulo-oculofacial syndrome A syndrome of bony anomalies of the calvaria, face, and jaw, with brachygnathia, narrow curved nose, and multiple ocular defects including microphthalmia, microcornea, and cataract, often with alopecia overlying skull sutures, or alopecia areata and hypoplasia, or absence of eyebrows. The pattern of inheritance is undecided.
Synonym: congenital sutural alopecia, Hallermann-Streiff syndrome, Hallermann-Streiff-Francois syndrome, mandibulo-oculofacial syndrome, oculomandibulodyscephaly, oculomandibulofacial syndrome, progeria with cataract, progeria with microphthalmia.
(05 Mar 2000)
gender dysphoria syndrome <syndrome> A syndrome in which an individual experiences marked personal stress due to feelings that despite having the genitalia and secondary sexual characteristics of one gender there is a sense of compatibility and greater belonging to the other gender class; one may undergo surgery to reconstruct anatomy to that of the other gender.
(05 Mar 2000)
general adaptation syndrome <syndrome> The sum of all non-specific systemic reactions of the body to long-continued exposure to systemic stress.
(12 Dec 1998)
Raynaud's syndrome <syndrome> Idiopathic paroxysmal bilateral cyanosis of the digits due to arterial and arteriolar contraction; caused by cold or emotion.
See: Raynaud's phenomenon.
Synonym: Raynaud's disease, symmetric asphyxia.
(05 Mar 2000)
Maranon's syndrome <syndrome> A syndrome characterised by ovarian insufficiency, scoliosis, and flat-feet.
(05 Mar 2000)
paraneoplastic syndrome <oncology, syndrome> A collection of symptoms or clinical signs that are found in patients that have malignant disease. By definition, the signs and symptoms are not produced by a direct effect of a tumour or its metastasis nor due to direct invasion, compression, metastasis, infection, nutritional deficiency or treatment of the underlying neoplasm.
Paraneoplastic syndromes can arise from tumour produced biologically active polypeptides or proteins, autoimmunity or immune complex production and immune suppression, blockade of the normal effect of a hormone, the release of substances from tumour associated endothelium which are not normally released and finally unknown causes.
The best characterised paraneoplastic syndrome is the syndrome of inappropriate ADH.
(15 Dec 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á